Sanolla
Cardiopulmonary Diagnosis, Monitoring, and Screening
Company Overview
Snapshot
Founded in April 2016 by Doron Adler and Dudu Linhard, Sanolla operates with 11–50 employees. The company has raised $16M across 6 funding rounds from 4 investors. In April 2022, Sanolla received funding from Together We Invest and KYTO.
Business overview
Sanolla develops smart diagnostic solutions for physicians and patients, focusing on the early assessment and monitoring of cardiopulmonary conditions such as congestive heart failure, pneumonia, asthma, chronic obstructive pulmonary disease, and COVID-19. Its core technology utilizes AI-powered detection and analysis of body infrasounds and other vital signs, including ECG, heart rate, oxygen level, body temperature, and respiratory cycle. The company's products, including VoqX, SonoX, and PyXy, aim to provide immediate and accurate assessments, reducing the need for in-clinic visits and lowering infection exposure risks. Sanolla operates in the Health Tech & Life Sciences sector, specifically within Medical Devices and Digital Healthcare, serving markets across North America, Europe, Southeast Asia, and Oceania.
Strategic signal
In September 2025, Sanolla is set to launch its VoqX smart stethoscope, which will offer full-spectrum auscultation through AI-powered technology. This launch signals a significant advancement in diagnostic tools, potentially enhancing early detection and monitoring capabilities for various cardiopulmonary conditions and validating Sanolla's leadership in advanced auscultation and AI-powered diagnostics.
Log in to access full profile ›Company Intelligence Q&A
- What is Sanolla's primary focus?
- Sanolla focuses on providing smart diagnostic solutions for the early assessment and monitoring of cardiopulmonary conditions, utilizing AI-powered detection of body infrasounds and other vital signs.
- When was Sanolla founded and by whom?
- Sanolla was founded in April 2016 by Doron Adler and Dudu Linhard.
- What is the key technology behind Sanolla's products?
- Sanolla's products are based on AI-powered detection and analysis of previously inaccessible body infrasounds, combined with other vital signs such as ECG, heart rate, oxygen level, body temperature, and respiratory cycle.
- What significant product launch is Sanolla planning?
- In September 2025, Sanolla is launching its VoqX smart stethoscope, which features AI-powered full-spectrum auscultation.